News › Industry News

Merz Aesthetics Continues Multi-Year ‘Beauty on Your Terms’ Campaign for Xeomin with Announcement of Demi Lovato as New Brand Partner

March 7, 2024
Merz Aesthetics

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced the latest extension of their first-of-its kind, multi-year campaign, ‘Beauty on Your Terms’ with the addition of award-winning actor and musician Demi Lovato as the newest Xeomin (incobotulinumtoxinA) brand partner.

The partnership with Lovato is a continuation of Merz Aesthetics’ multi-channel, digital-first ‘Beauty on Your Terms’ campaign, which has reimagined traditional pharmaceutical marketing strategy. First launched in August 2022, the campaign was developed to introduce Xeomin, an FDA-approved double-filtered anti-wrinkle injection to temporarily improve the appearance of frown lines, to a younger adult audience that is new to the injectables category and to empower them to embrace beauty on their own terms.

Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
Advertisement